Genmab - ADR

Genmab - ADR


Market Cap$18.01B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Genmab - ADRGenmab - ADR00%-1.1-

Target Price by Analysts

79.3% upsideGenmab Target Price DetailsTarget Price

Share Statistics

Market cap$18.01 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares661,299,230
Avg 30 Day Volume530,335


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales1.07
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Genmab

CEO: Jan van de Winkel